Foghorn Therapeutics
FHTX • NASDAQ • Stock Fundamentals
Foghorn Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Adrian H. Gottschalk, with a market cap of $238.4M.
Market Cap$238.4M
Employees116.0
CEOAdrian H. Gottschalk
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 4, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Foghorn Therapeutics FAQ
Common questions about Foghorn Therapeutics
Foghorn Therapeutics (FHTX) has a market capitalization of $238.4M and trades on NASDAQ.
Foghorn Therapeutics has approximately 116 employees.